OBI Pharma Inc
TPEX:4174
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OBI Pharma Inc
TPEX:4174
|
TW |
|
Auris Minerals Ltd
OTC:AURMF
|
AU |
|
Basanite Inc
OTC:BASA
|
US |
|
O
|
Opdenergy Holding SA
F:69J
|
ES |
Shareholder Yield
Current shareholder yield for OBI Pharma Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
OBI Pharma Inc
| Average Annual Return | -9.99% |
| Standard Deviation of Annual Returns | 22.2% |
| Max Drawdown | -100% |
| Market Capitalization | 3.5B TWD |
| Shares Outstanding | 131 580 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
OBI Pharma Inc's latest stock split occurred on Jan 27, 2026
The company executed a 500-for-1000 stock split, meaning that for every 1000 shares held, investors received 500 new shares.
Before the split, OBI Pharma Inc traded at 55.2 per share. Afterward, the share price was about 55.2.
The adjusted shares began trading on Jan 27, 2026. This was the only stock split in OBI Pharma Inc's history.
